Healthcare DIVE May 16, 2017
Dive Brief:
- The shift to value-based care will transform healthcare companies’ business strategies in the coming years, a new Lazard survey of global industry leaders suggests.
- Adoption of value-based or risk-sharing pricing models will be disruptive over the next five to 10 years, according to 47% of the surveyed C-suite executives and investors in the U.S. and European pharma/biotech, medical devices/technology and healthcare services sectors.
- In the U.S., respondents expected little slowdown under the President Donald Trump administration — with more than half (55%) predicting a majority of U.S. healthcare payments being value-based by 2020.
Dive Insight:
With the rapidly changing healthcare environment, many organizations in the industry are looking to partner with entities rather than purchase them...